An official American thoracic society research statement: Current understanding and future research needs in Tobacco control and treatment

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 3, 2015, Pages e22-e41

  Leone, Frank T ^a   Carlsen, Kai Hakon ^a   Folan, Patricia ^a   Latzka, Karen ^a   Munzer, Alfred ^a   Neptune, Enid ^a   Pakhale, Smita ^a   Sachs, David P L ^a   Samet, Jonathan ^a   Upson, Dona ^a   White, Alexander ^a  

^a 4 Penn Ctr   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE CONTROL; ENVIRONMENTAL EXPOSURE; EPIDEMIC; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; TOBACCO DEPENDENCE; CONSENSUS DEVELOPMENT; FEMALE; FETOMATERNAL TRANSFUSION; FORECASTING; MALE; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; PREGNANCY; SMOKING CESSATION; TOBACCO USE DISORDER; TRENDS; UNITED STATES;

BIOMEDICAL RESEARCH; FEMALE; FORECASTING; HUMANS; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; SMOKING CESSATION; SOCIETIES, MEDICAL; TOBACCO USE DISORDER; UNITED STATES;

EID: 84938892410     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201506-1081ST     Document Type: Article

References (240)

1. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The health consequences of smoking-50 years of progress: a report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention (US). 2014 [accessed 2014 Apr 13]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK179276/
2. Agaku IT, King BA, Dube SR; Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults: United States, 2005-2012. MMWR Morb Mortal Wkly Rep 2014;63: 29-34.
3. Centers for Disease Control and Prevention (CDC). State-specific prevalence of cigarette smoking and smokeless tobacco use among adults: United States, 2009. MMWR Morb Mortal Wkly Rep 2010;59: 1400-1406.
4. World Health Organization. Tobacco fact sheet No. 339. 2013 Jun [updated 2015 May; accessed 2014 Apr 13]. Available from: http://www.who.int/mediacentre/factsheets/fs339/en/
5. World Health Organization. WHO Framework Convention on Tobacco Control. [accessed 2015 Jul 16]. Available from: http://www.who.int/fctc/en/
6. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. Preventing tobacco use among youth and young adults: a report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention (US). 2012 [accessed 2014 Apr 13]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK99237/
7. National Cancer Institute. The role of the media in promoting and reducing tobacco use. Tobacco Control Monograph No. 19. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2008.
8. Mayer KH, Bradford JB, Makadon HJ, Stall R, Goldhammer H, Landers S. Sexual and gender minority health: what we know and what needs to be done. Am J Public Health 2008;98:989-995.
9. Lee JGL, Griffin GK, Melvin CL. Tobacco use among sexual minorities in the USA, 1987 to May 2007: a systematic review. Tob Control 2009;18:275-282.
10. Kann L, Olsen EO, McManus T, Kinchen S, Chyen D, Harris WA, Wechsler H. Sexual identity, sex of sexual contacts, and health-risk behaviors among students in grades 9-12-youth risk behavior surveillance, selected sites, United States, 2001-2009. MMWR Surveill Summ 2011;60:1-133.
11. Matthews AK, Li C-C, Kuhns LM, Tasker TB, Cesario JA. Results from a community-based smoking cessation treatment program for LGBT smokers. J Environ Public Health 2013;2013:984508.
12. Reeves WC, Strine TW, Pratt LA, Thompson W, Ahluwalia I, Dhingra SS, McKnight-Eily LR, Harrison L, D'Angelo DV, Williams L, et al. Mental illness surveillance among adults in the United States. MMWR Surveill Summ 2011;60:1-29.
13. Centers for Disease Control and Prevention (CDC). Vital signs: current cigarette smoking among adults aged 18 years with mental illness-United States, 2009-2011. MMWR Morb Mortal Wkly Rep 2013;62:81-87.
14. Banham L, Gilbody S. Smoking cessation in severe mental illness: what works? Addiction 2010;105:1176-1189.
15. Williams JM, Foulds J. Successful tobacco dependence treatment in schizophrenia. Am J Psychiatry 2007;164:222-227, quiz 373.
16. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev 2013;2:CD007253.
17. Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, George TP. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry 2012;73:654-660.
18. Cavazos-Rehg PA, Breslau N, Hatsukami D, Krauss MJ, Spitznagel EL, Grucza RA, Salyer P, Hartz SM, Bierut LJ. Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disorders. Psychol Med 2014;44:2523-2535.
19. Bolam B, West R, Gunnell D. Does smoking cessation cause depression and anxiety? Findings from the ATTEMPT cohort. Nicotine Tob Res 2011;13:209-214.
20. Glaze L. Correctional populations in the United States, 2010. 2011 Dec [accessed 2014 Apr 13]. Available from: www.bjs.gov/content/pub/pdf/cpus10.pdf
21. Cropsey KL, Jones-Whaley S, Jackson DO, Hale GJ. Smoking characteristics of community corrections clients. Nicotine Tob Res 2010;12:53-58.
22. Cropsey K, Eldridge G, Weaver M, Villalobos G, Stitzer M, Best A. Smoking cessation intervention for female prisoners: addressing an urgent public health need. Am J Public Health 2008;98:1894-1901.
23. US Census Bureau. Income, poverty and health insurance coverage in the United States: 2012. Income & wealth-newsroom [accessed 2015 Jul 16]. Available from: http://www.census.gov/newsroom/releases/archives/income-wealth/cb13-165.html
24. Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults: United States, 2011. MMWR Morb Mortal Wkly Rep 2012;61:889-894.
25. Baggett TP, Tobey ML, Rigotti NA. Tobacco use among homeless people: addressing the neglected addiction. N Engl J Med 2013; 369:201-204.
26. Brown DW. Smoking prevalence among US veterans. J Gen Intern Med 2010;25:147-149.
27. The Office of Adolescent Health. US Department of Health and Human Services. Office of Adolescent Health [accessed 2015 Jul 16]. Available from: http://www.hhs.gov/ash/oah/
28. Hale D, Viner R. Trends in the prevalence of multiple substance use in adolescents in England, 1998-2009. J Public Health (Oxf) 2013;35: 367-374.
29. Konfino J, Ferrante D, Goldberg L, Caixeta R, Palipudi KM; Centers for Disease Control and Prevention. Tobacco use among youths: Argentina, 2007 and 2012. MMWR Morb Mortal Wkly Rep 2014;63: 588-590.
30. Centers for Disease Control and Prevention (CDC). Current tobacco use among middle and high school students: United States, 2011. MMWR Morb Mortal Wkly Rep 2012;61:581-585.
31. Centers for Disease Control and Prevention (CDC). High school students who tried to quit smoking cigarettes: United States, 2007. MMWR Morb Mortal Wkly Rep 2009;58:428-431.
32. Stanton A, Grimshaw G. Tobacco cessation interventions for young people. Cochrane Database Syst Rev 2013;8:CD003289.
33. Lovato C, Watts A, Stead LF. Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours. Cochrane Database Syst Rev 2011;10:CD003439.
34. Morgenstern M, Sargent JD, Isensee B, Hanewinkel R. From never to daily smoking in 30 months: the predictive value of tobacco and non-tobacco advertising exposure. BMJ Open 2013;3.
35. Paynter J, Edwards R. The impact of tobacco promotion at the point of sale: a systematic review. Nicotine Tob Res 2009;11:25-35.
36. Henriksen L. Comprehensive tobacco marketing restrictions: promotion, packaging, price and place. Tob Control 2012;21: 147-153.
37. Clattenburg EJ, Elf JL, Apelberg BJ. Unplanned cigarette purchases and tobacco point of sale advertising: a potential barrier to smoking cessation. Tob Control 2013;22:376-381.
38. Henriksen L, Feighery EC, Schleicher NC, Haladjian HH, Fortmann SP. Reaching youth at the point of sale: cigarette marketing is more prevalent in stores where adolescents shop frequently. Tob Control 2004;13:315-318.
39. Lovato CY, Hsu HCH, Sabiston CM, Hadd V, Nykiforuk CIJ. Tobacco point-of-purchase marketing in school neighbourhoods and school smoking prevalence: a descriptive study. Can J Public Health 2007;98:265-270.
40. Dauphinee AL, Doxey JR, Schleicher NC, Fortmann SP, Henriksen L. Racial differences in cigarette brand recognition and impact on youth smoking. BMC Public Health 2013;13:170.
41. Duke JC, Allen JA, Pederson LL, Mowery PD, Xiao H, Sargent JD. Reported exposure to pro-tobacco messages in the media: trends among youth in the United States, 2000-2004. Am J Health Promot 2009;23:195-202.
42. Jenssen BP, Klein JD, Salazar LF, Daluga NA, DiClemente RJ. Exposure to tobacco on the Internet: content analysis of adolescents' Internet use. Pediatrics 2009;124:e180-e186.
43. Forsyth SR, Kennedy C, Malone RE. The effect of the Internet on teen and young adult tobacco use: a literature review. J Pediatr Health Care 2013;27:367-376.
44. Proctor R. Golden holocaust: origins of the cigarette catastrophe and the case for abolition. Berkeley, CA: University of California Press; 2012.
45. Sargent JD, Beach ML, Adachi-Mejia AM, Gibson JJ, Titus-Ernstoff LT, Carusi CP, Swain SD, Heatherton TF, Dalton MA. Exposure to movie smoking: its relation to smoking initiation among US adolescents. Pediatrics 2005;116:1183-1191.
46. Morgenstern M, Sargent JD, Engels RCME, Scholte RHJ, Florek E, Hunt K, Sweeting H, Mathis F, Faggiano F, Hanewinkel R. Smoking in movies and adolescent smoking initiation: longitudinal study in six European countries. Am J Prev Med 2013;44:339-344.
47. Glantz SA, Iaccopucci A, Titus K, Polansky JR. Smoking in top-grossing US movies, 2011. Prev Chronic Dis 2012;9:120170.
48. National Association of Attorneys General. Movie studios should stop depicting smoking in youth-rated movies [accessed 2015 Jul 16]. Available from: http://www.naag.org/naag/media/naag-news/movie-studios-should-stop-depicting-smoking-in-youth-rated-movies.php
49. Centers for Disease Control and Prevention. Fact sheet. Smoking in the movies: smoking & tobacco use [accessed 2015 Jul 16]. Available from: http://www.cdc.gov/tobacco/data-statistics/fact-sheets/youth-data/movies/index.htm
50. Lee JGL, Agnew-Brune CB, Clapp JA, Blosnich JR. Out smoking on the big screen: tobacco use in LGBT movies, 2000-2011. Tob Control 2014;23:e156-e158.
51. Dal Cin S, Stoolmiller M, Sargent JD. Exposure to smoking in movies and smoking initiation among black youth. Am J Prev Med 2013; 44:345-350.
52. Tanski SE, Stoolmiller M, Gerrard M, Sargent JD. Moderation of the association between media exposure and youth smoking onset: race/ethnicity, and parent smoking. Prev Sci 2012;13:55-63.
53. Wilkinson AV, Spitz MR, Prokhorov AV, Bondy ML, Shete S, Sargent JD. Exposure to smoking imagery in the movies and experimenting with cigarettes among Mexican heritage youth. Cancer Epidemiol Biomarkers Prev 2009;18:3435-3443.
54. DiFranza JR, Savageau JA, Fletcher K, O'Loughlin J, Pbert L, Ockene JK, McNeill AD, Hazelton J, Friedman K, Dussault G, et al. Symptoms of tobacco dependence after brief intermittent use: the Development and Assessment of Nicotine Dependence in Youth-2 study. Arch Pediatr Adolesc Med 2007;161:704-710.
55. Centers for Disease Control and Prevention (CDC). Tobacco product use among middle and high school students: United States, 2011 and 2012. MMWR Morb Mortal Wkly Rep 2013;62:893-897.
56. U.S. Food and Drug Administration. Press announcements: FDA proposes to extend its tobacco authority to additional tobacco products, including e-cigarettes. 2014 Apr 24 [accessed 2014 May 16]. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm394667.htm
57. Hatzenbuehler ML, Phelan JC, Link BG. Stigma as a fundamental cause of population health inequalities. Am J Public Health 2013; 103:813-821.
58. Reducing Tobacco Use. Reducing tobacco use: a report of the Surgeon General. Executive Summary. MMWR Recomm Rep 2000;49:1-27.
59. Blosnich JR, Farmer GW, Lee JGL, Silenzio VMB, Bowen DJ. Health inequalities among sexual minority adults: evidence from ten U.S. states, 2010. Am J Prev Med 2014;46:337-349.
60. Corliss HL, Wadler BM, Jun H-J, Rosario M, Wypij D, Frazier AL, Austin SB. Sexual-orientation disparities in cigarette smoking in a longitudinal cohort study of adolescents. Nicotine Tob Res 2013;15:213-222.
61. Blosnich JR, Horn K. Associations of discrimination and violence with smoking among emerging adults: differences by gender and sexual orientation. Nicotine Tob Res 2011;13: 1284-1295.
62. Blosnich J, Lee JGL, Horn K. A systematic review of the aetiology of tobacco disparities for sexual minorities. Tob Control 2013;22:66-73.
63. Rosario M, Schrimshaw EW, Hunter J. Disclosure of sexual orientation and subsequent substance use and abuse among lesbian, gay, and bisexual youths: critical role of disclosure reactions. Psychol Addict Behav 2009;23:175-184.
64. Moskowitz A, Stein JA, Lightfoot M. The mediating roles of stress and maladaptive behaviors on self-harm and suicide attempts among runaway and homeless youth. J Youth Adolesc 2013;42: 1015-1027.
65. Stevens P, Carlson LM, Hinman JM. An analysis of tobacco industry marketing to lesbian, gay, bisexual, and transgender (LGBT) populations: strategies for mainstream tobacco control and prevention. Health Promot Pract 2004;5:129S-134S.
66. Smith EA, Thomson K, Offen N, Malone RE. "If you know you exist, it's just marketing poison": meanings of tobacco industry targeting in the lesbian, gay, bisexual, and transgender community. Am J Public Health 2008;98:996-1003.
67. Penaloza L. We're here, we're queer, and we're going shopping! A critical perspective on the accommodation of gays and lesbians in the US marketplace. In: Wardlow DL, ed. Gays, lesbians, and consumer behavior: theory, practice and research issues in marketing. New York: Haworth; 1996. pp. 9-41.
68. Institute of Medicine. The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding. Institute of Medicine [accessed 2015 Jul 16]. Available from: http://www.iom.edu/Reports/2011/The-Health-of-Lesbian-Gay-Bisexual-and-Transgender-People.aspx
69. Centers for Disease Control and Prevention (US), National Center for Chronic Disease Prevention and Health Promotion (US), Office on Smoking and Health (US). How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention (US). 2010 [accessed 2014 Apr 14]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK53017/
70. Benowitz NL. Nicotine addiction. N Engl J Med 2010;362:2295-2303.
71. Rossing MA. Genetic influences on smoking: candidate genes. Environ Health Perspect 1998;106:231-238.
72. Shiffman S. Refining models of dependence: variations across persons and situations. Br J Addict 1991;86:611-615.
73. Sargent JD, Hanewinkel R. Comparing the effects of entertainment media and tobacco marketing on youth smoking in Germany. Addiction 2009;104:815-823.
74. Sargent JD, Gibson J, Heatherton TF. Comparing the effects of entertainment media and tobacco marketing on youth smoking. Tob Control 2009;18:47-53.
75. Titus-Ernstoff L, Dalton MA, Adachi-Mejia AM, Longacre MR, Beach ML. Longitudinal study of viewing smoking in movies and initiation of smoking by children. Pediatrics 2008;121:15-21.
76. Coady MH, Chan CA, Auer K, Farley SM, Kilgore EA, Kansagra SM. Awareness and impact of New York City's graphic point-of-sale tobacco health warning signs. Tob Control 2013;22:e51-e56.
77. Hammond D, Fong GT, Borland R, Cummings KM, McNeill A, Driezen P. Text and graphic warnings on cigarette packages: findings from the international tobacco control four country study. Am J Prev Med 2007;32:202-209.
78. Centers for Disease Control and Prevention (CDC). Cigarette package health warnings and interest in quitting smoking: 14 countries, 2008-2010. MMWR Morb Mortal Wkly Rep 2011;60:645-651.
79. Disc. Tobacco City & Lottery, Inc. v. United States. Justia Law [accessed 2015 Jul 16]. Available from: http://law.justia.com/cases/federal/appellate-courts/ca6/10-5235/10-5235-2012-03-19.html
80. Gilpin EA, White MM, Messer K, Pierce JP. Receptivity to tobacco advertising and promotions among young adolescents as a predictor of established smoking in young adulthood. Am J Public Health 2007;97:1489-1495.
81. Germain D, Wakefield MA, Durkin SJ. Adolescents' perceptions of cigarette brand image: does plain packaging make a difference? J Adolesc Health 2010;46:385-392.
82. Farrelly MC, Nonnemaker J, Davis KC, Hussin A. The Influence of the National Truth Campaign on smoking initiation. Am J Prev Med 2009;36:379-384.
83. Gladwell M. The tipping point: how little things can make a big difference, 1st ed. Boston: Little, Brown; 2000.
84. National Cancer Institute. Greater than the sum: systems thinking in tobacco control. Tobacco Control Monograph No. 18. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2007.
85. Surgeon General's Advisory Committee on Smoking and Health. United States Public Health Service, Office of the Surgeon General. Smoking and health. Public Health Service Publication No. 1103. 1964 [accessed 2013 Nov 19]. Available from: http://profiles.nlm.nih.gov/NN/B/B/M/Q/
86. United States Public Health Service, Office on Smoking and Health. United States Public Health Service, Office of the Surgeon General. The health consequences of involuntary smoking: a report of the Surgeon General. Department of Health and Human Services Publication No. (CDC) 87-8398. 1986 [accessed 2014 Apr 14]. Available from: http://profiles.nlm.nih.gov/NN/B/C/P/M/
87. Wang X, Tager IB, Van Vunakis H, Speizer FE, Hanrahan JP. Maternal smoking during pregnancy, urine cotinine concentrations, and birth outcomes. A prospective cohort study. Int J Epidemiol 1997; 26:978-988.
88. Bastek JA, Sammel MD, Srinivas SK, McShea MA, Foreman MN, Elovitz MA, Metlay JP. Clinical prediction rules for preterm birth in patients presenting with preterm labor. Obstet Gynecol 2012;119: 1119-1128.
89. Martinez FD, Wright AL, Taussig LM; Group Health Medical Associates. The effect of paternal smoking on the birthweight of newborns whose mothers did not smoke. Am J Public Health 1994; 84:1489-1491.
90. Hackshaw A, Rodeck C, Boniface S. Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. Hum Reprod Update 2011;17:589-604.
91. Anderson HR, Cook DG. Passive smoking and sudden infant death syndrome: review of the epidemiological evidence. Thorax 1997; 52:1003-1009.
92. Elliot J, Vullermin P, Robinson P. Maternal cigarette smoking is associated with increased inner airway wall thickness in children who die from sudden infant death syndrome. Am J Respir Crit Care Med 1998;158:802-806.
93. Tager IB, Ngo L, Hanrahan JP. Maternal smoking during pregnancy. Effects on lung function during the first 18 months of life. Am J Respir Crit Care Med 1995;152:977-983.
94. Lødrup Carlsen KC, Jaakkola JJ, Nafstad P, Carlsen KH. In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J 1997;10:1774-1779.
95. Hoo AF, Henschen M, Dezateux C, Costeloe K, Stocks J. Respiratory function among preterm infants whose mothers smoked during pregnancy. Am J Respir Crit Care Med 1998;158:700-705.
96. Sekhon HS, Keller JA, Benowitz NL, Spindel ER. Prenatal nicotine exposure alters pulmonary function in newborn rhesus monkeys. Am J Respir Crit Care Med 2001;164:989-994.
97. Sekhon HS, Keller JA, Proskocil BJ, Martin EL, Spindel ER. Maternal nicotine exposure upregulates collagen gene expression in fetal monkey lung: association with alpha7 nicotinic acetylcholine receptors. Am J Respir Cell Mol Biol 2002;26:31-41.
98. Maritz GS, Dennis H. Maternal nicotine exposure during gestation and lactation interferes with alveolar development in the neonatal lung. Reprod Fertil Dev 1998;10:255-261.
99. Sekhon HS, Jia Y, Raab R, Kuryatov A, Pankow JF, Whitsett JA, Lindstrom J, Spindel ER. Prenatal nicotine increases pulmonary alpha7 nicotinic receptor expression and alters fetal lung development in monkeys. J Clin Invest 1999;103:637-647.
100. Wongtrakool C, Roser-Page S, Rivera HN, Roman J. Nicotine alters lung branching morphogenesis through the a7 nicotinic acetylcholine receptor. Am J Physiol Lung Cell Mol Physiol 2007; 293:L611-L618.
101. Gilliland FD, Berhane K, Li Y-F, Rappaport EB, Peters JM. Effects of early onset asthma and in utero exposure to maternal smoking on childhood lung function. Am J Respir Crit Care Med 2003;167: 917-924.
102. Wang C, Salam MT, Islam T, Wenten M, Gauderman WJ, Gilliland FD. Effects of in utero and childhood tobacco smoke exposure and beta2-adrenergic receptor genotype on childhood asthma and wheezing. Pediatrics 2008;122:e107-e114.
103. Breton CV, Salam MT, Gilliland FD. Heritability and role for the environment in DNA methylation in AXL receptor tyrosine kinase. Epigenetics 2011;6:895-898.
104. Terry MB, Ferris JS, Pilsner R, Flom JD, Tehranifar P, Santella RM, Gamble MV, Susser E. Genomic DNA methylation among women in a multiethnic New York City birth cohort. Cancer Epidemiol Biomarkers Prev 2008;17:2306-2310.
105. Li Y-F, Langholz B, Salam MT, Gilliland FD. Maternal and grandmaternal smoking patterns are associated with early childhood asthma. Chest 2005;127:1232-1241.
106. Baba S, Wikström A-K, Stephansson O, Cnattingius S. Influence of smoking and snuff cessation on risk of preterm birth. Eur J Epidemiol 2012;27:297-304.
107. Schneider S, Schütz J. Who smokes during pregnancy? A systematic literature review of population-based surveys conducted in developed countries between 1997 and 2006. Eur J Contracept Reprod Health Care 2008;13:138-147.
108. Al-Sahab B, Saqib M, Hauser G, Tamim H. Prevalence of smoking during pregnancy and associated risk factors among Canadian women: a national survey. BMC Pregnancy Childbirth 2010; 10:24.
109. Erickson AC, Arbour LT. Heavy smoking during pregnancy as a marker for other risk factors of adverse birth outcomes: a population-based study in British Columbia, Canada. BMC Public Health 2012;12:102.
110. Tong VT, Dietz PM, England LJ, Farr SL, Kim SY, D'Angelo D, Bombard JM. Age and racial/ethnic disparities in prepregnancy smoking among women who delivered live births. Prev Chronic Dis 2011;8:A121.
111. Centers for Disease Control and Prevention. Tobacco use and pregnancy: reproductive health [accessed 2015 Jul 16]. Available from: http://www.cdc.gov/reproductivehealth/TobaccoUsePregnancy/
112. Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res 2004;6:S125-S140.
113. Atrash HK, Hughes JM, Hogue CJ. Ectopic pregnancy in the United States, 1970-1983. MMWR CDC Surveill Summ 1986;35: 29SS-37SS.
114. Office on Smoking and Health (US). Women and smoking: a report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention (US). 2001 [accessed 2014 May 14]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK44303/
115. Svensson AC, Pawitan Y, Cnattingius S, Reilly M, Lichtenstein P. Familial aggregation of small-for-gestational-age births: the importance of fetal genetic effects. Am J Obstet Gynecol 2006; 194:475-479.
116. Ananth CV, Savitz DA, Luther ER. Maternal cigarette smoking as a risk factor for placental abruption, placenta previa, and uterine bleeding in pregnancy. Am J Epidemiol 1996;144:881-889.
117. Faruque MO, Khan MR, Rahman MM, Ahmed F. Relationship between smoking and antioxidant nutrient status. Br J Nutr 1995; 73:625-632.
118. Centers for Disease Control and Prevention. Patterns of tobacco use among women and girls. Smoking and tobacco use [accessed 2015 Jul 16]. Available from: http://www.cdc.gov/tobacco/data-statistics/sgr/2001/highlights/tobaccouse/
119. Aydogan U, Durmaz E, Ercan CM, Eken A, Ulutas OK, Kavuk S, Gursel O, Alanbay I, Akay C, Kurekci AE, et al. Effects of smoking during pregnancy on DNA damage and ROS level consequences in maternal and newborns' blood. Arh Hig Rada Toksikol 2013;64: 35-46.
120. Chelchowska M, Ambroszkiewicz J, Gajewska J, Laskowska-Klita T, Leibschang J. The effect of tobacco smoking during pregnancy on plasma oxidant and antioxidant status in mother and newborn. Eur J Obstet Gynecol Reprod Biol 2011;155:132-136.
121. Chełchowska M, Jabłonka-Salach K, Ambroszkiewicz J, Maciejewski T, Gajewska J, Bulska E, Laskowska-Klita T, Leibschang J, Barciszewski J. Effect of cigarette smoking on blood lead levels in pregnant women [in Polish]. Med Wieku Rozwoj 2012;16:196-204.
122. Banihosseini SZ, Baheiraei A, Shirzad N, Heshmat R, Mohsenifar A. The effect of cigarette smoke exposure on vitamin D level and biochemical parameters of mothers and neonates. J Diabetes Metab Disord 2013;12:19.
123. Vio F, Salazar G, Infante C. Smoking during pregnancy and lactation and its effects on breast-milk volume. Am J Clin Nutr 1991;54: 1011-1016.
124. Etem Pişkin I, Nur Karavar H, Arasli M, Ermiş B. Effect of maternal smoking on colostrum and breast milk cytokines. Eur Cytokine Netw 2012;23:187-190.
125. Schneider S, Huy C, Schütz J, Diehl K. Smoking cessation during pregnancy: a systematic literature review. Drug Alcohol Rev 2010; 29:81-90.
126. Lumley J, Chamberlain C, Dowswell T, Oliver S, Oakley L, Watson L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2009;3:CD001055.
127. Coleman T, Chamberlain C, Davey M-A, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2012; 9:CD010078.
128. Fiore M, Jaén C, Baker T, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services. Public Health Service; 2008.
129. Kruger J, Shaw L, Kahende J, Frank E. Health care providers' advice to quit smoking, National Health Interview Survey, 2000, 2005, and 2010. Prev Chronic Dis 2012;9:E130.
130. Bernstein SL, Yu S, Post LA, Dziura J, Rigotti NA. Undertreatment of tobacco use relative to other chronic conditions. Am J Public Health 2013;103:e59-e65.
131. Conroy MB, Majchrzak NE, Regan S, Silverman CB, Schneider LI, Rigotti NA. The association between patient-reported receipt of tobacco intervention at a primary care visit and smokers' satisfaction with their health care. Nicotine Tob Res 2005;7: S29-S34.
132. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev 2008;2:CD000165.
133. Woods SS, Jaen CR. Increasing consumer demand for tobacco treatments: ten design recommendations for clinicians and healthcare systems. Am J Prev Med 2010;38:S385-S392.
134. Bryant J, Bonevski B, Paul C, O'Brien J, Oakes W. Developing cessation interventions for the social and community service setting: a qualitative study of barriers to quitting among disadvantaged Australian smokers. BMC Public Health 2011;11:493.
135. Mann-Wrobel MC, Bennett ME, Weiner EE, Buchanan RW, Ball MP. Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program. Schizophr Res 2011;126:277-283.
136. Roddy E, Antoniak M, Britton J, Molyneux A, Lewis S. Barriers and motivators to gaining access to smoking cessation services amongst deprived smokers-a qualitative study. BMC Health Serv Res 2006;6:147.
137. Ferguson SG, Gitchell JG, Shiffman S, Sembower MA, Rohay JM, Allen J. Providing accurate safety information may increase a smoker's willingness to use nicotine replacement therapy as part of a quit attempt. Addict Behav 2011;36:713-716.
138. Secondhand smoke: awareness, attitudes and exposure among Wisconsin residents [accessed 2015 Jul 16]. Available from: http://www.ctri.wisc.edu/Publications/publications/Secondhandsmoke.pdf
139. Czarnecki KD, Vichinsky LE, Ellis JA, Perl SB. Media campaign effectiveness in promoting a smoking-cessation program. Am J Prev Med 2010;38:S333-S342.
140. Pipe A, Sorensen M, Reid R. Physician smoking status, attitudes toward smoking, and cessation advice to patients: an international survey. Patient Educ Couns 2009;74:118-123.
141. Ceraso M, McElroy JA, Kuang X, Vila PM, Du X, Lu L, Ren H, Qian N, Jorenby DE, Fiore MC. Smoking, barriers to quitting, and smoking-related knowledge, attitudes, and patient practices among male physicians in China. Prev Chronic Dis 2009;6:A06.
142. Tong EK, Strouse R, Hall J, Kovac M, Schroeder SA. National survey of U.S. health professionals' smoking prevalence, cessation practices, and beliefs. Nicotine Tob Res 2010;12:724-733.
143. Stead M, Angus K, Holme I, Cohen D, Tait G; PESCE European Research Team. Factors influencing European GPs' engagement in smoking cessation: a multi-country literature review. Br J Gen Pract 2009;59:682-690.
144. Weiner B. On sin versus sickness: a theory of perceived responsibility and social motivation. Am Psychol 1993;48: 957-965.
145. Brewin CR. Perceived controllability of life-events and willingness to prescribe psychotropic drugs. Br J Soc Psychol 1984;23: 285-287.
146. Weiner B. An attributional theory of achievement motivation and emotion. Psychol Rev 1985;92:548-573.
147. Weiner B, Perry RP, Magnusson J. An attributional analysis of reactions to stigmas. J Pers Soc Psychol 1988;55:738-748.
148. Legacy Tobacco Documents Library. Ammonia [accessed 2015 Jul 16]. Available from: http://legacy.library.ucsf.edu/tid/gfx65d00
149. Legacy Tobacco Documents Library. Root technology: a handbook for leaf binders [accessed 2015 Jul 16]. Available from: http://legacy.library.ucsf.edu/tid/dlh01c00
150. Ferris Wayne G, Connolly GN, Henningfield JE. Brand differences of free-base nicotine delivery in cigarette smoke: the view of the tobacco industry documents. Tob Control 2006;15:189-198.
151. Pankow JF, Tavakoli AD, Luo W, Isabelle LM. Percent free base nicotine in the tobacco smoke particulate matter of selected commercial and reference cigarettes. Chem Res Toxicol 2003;16: 1014-1018.
152. Lunell E, Molander L, Ekberg K, Wahren J. Site of nicotine absorption from a vapour inhaler: comparison with cigarette smoking. Eur J Clin Pharmacol 2000;55:737-741.
153. Leone FT, Evers-Casey S. Developing a rational approach to tobacco use treatment in pulmonary practice: a review of the biological basis of nicotine addiction. Clin Pulm Med 2012;19:53-61.
154. Alcaro A, Huber R, Panksepp J. Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Res Brain Res Rev 2007;56:283-321.
155. Henningfield JE. Behavioral pharmacology of cigarette smoking. In: Thompson T, Dews PB, Barrett JE, editors. Advances in behavioral pharmacology. Orlando, FL: Academic Press; 1984. pp. 131-210.
156. Sachs D, Leone F, Farber H, Bars M, Prezant D, Schane R, Graham L, Zelman-Lewis S. ACCP tobacco dependence treatment toolkit. American College of Chest Physicians tobacco-dependence treatment tool kit, 3rd ed. [accessed 2015 Jul 16]. Available from: http://tobaccodependence.chestnet.org
157. Menossi HS, Goudriaan AE, de Azevedo-Marques Perico C, Nicastri S, de Andrade AG, D'Elia G, Li CS, Castaldelli-Maia JM. Neural bases of pharmacological treatment of nicotine dependence-insights from functional brain imaging: a systematic review. CNS Drugs 2013;27:921-941.
158. Lerman C, Berrettini W. Elucidating the role of genetic factors in smoking behavior and nicotine dependence. Am J Med Genet B Neuropsychiatr Genet 2003;118B:48-54.
159. Picciotto MR, Addy NA, Mineur YS, Brunzell DH. It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol 2008;84:329-342.
160. Marks MJ, Burch JB, Collins AC. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther 1983;226:817-825.
161. Marks MJ, Stitzel JA, Collins AC. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther 1985;235:619-628.
162. Schwartz RD, Kellar KJ. Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 1983;220:214-216.
163. Schwartz RD, Kellar KJ. In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem 1985;45:427-433.
164. Benwell ME, Balfour DJ, Anderson JM. Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain. J Neurochem 1988;50:1243-1247.
165. Perry DC, Davila-Garća MI, Stockmeier CA, Kellar KJ. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther 1999;289: 1545-1552.
166. Breese CR, Marks MJ, Logel J, Adams CE, Sullivan B, Collins AC, Leonard S. Effect of smoking history on [3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther 1997;282:7-13.
167. Nisell M, Nomikos GG, Svensson TH. Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol Toxicol 1994;75:348-352.
168. Kellar KJ, Davila-Garća MI, Xiao Y. Pharmacology of neuronal nicotinic acetylcholine receptors: effects of acute and chronic nicotine. Nicotine Tob Res 1999;1:S117-120. [Discussion pp. S139-140.]
169. Henningfield JE. Measurement issues in cigarette smoking research: basic behavioral and physiological effects and patterns of nicotine self-administration. NIDA Res Monogr 1983;48:27-38.
170. Goldberg SR, Henningfield JE. Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of i.v. drug injection. Pharmacol Biochem Behav 1988; 30:227-234.
171. Rose JE, Sampson A, Levin ED, Henningfield JE. Mecamylamine increases nicotine preference and attenuates nicotine discrimination. Pharmacol Biochem Behav 1989;32:933-938.
172. Henningfield JE, Miyasato K, Jasinski DR. Cigarette smokers self-administer intravenous nicotine. Pharmacol Biochem Behav 1983;19:887-890.
173. Ator NA, Griffiths RR. Nicotine self-administration in baboons. Pharmacol Biochem Behav 1983;19:993-1003.
174. Goldberg SR, Spealman RD, Risner ME, Henningfield JE. Control of behavior by intravenous nicotine injections in laboratory animals. Pharmacol Biochem Behav 1983;19:1011-1020.
175. Henningfield JE, Goldberg SR. Control of behavior by intravenous nicotine injections in human subjects. Pharmacol Biochem Behav 1983;19:1021-1026.
176. Henningfield JE, Goldberg SR. Nicotine as a reinforcer in human subjects and laboratory animals. Pharmacol Biochem Behav 1983;19:989-992.
177. Hall BJ, Pearson LS, Buccafusco JJ. Effect of administration of the nicotinic acetylcholine receptor antagonist BTMPS, during nicotine self-administration, on lever responding induced by context long after withdrawal. Neuropharmacology 2010;58: 429-435.
178. Wignall ND, de Wit H. Effects of nicotine on attention and inhibitory control in healthy nonsmokers. Exp Clin Psychopharmacol 2011; 19:183-191.
179. Fagerström KO, Pomerleau O, Giordani B, Stelson F. Nicotine may relieve symptoms of Parkinson's disease. Psychopharmacology (Berl) 1994;116:117-119.
180. Newhouse P, Kellar K, Aisen P, White H, Wesnes K, Coderre E, Pfaff A, Wilkins H, Howard D, Levin ED. Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial. Neurology 2012;78:91-101.
181. Potter AS, Newhouse PA. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder. Pharmacol Biochem Behav 2008;88:407-417.
182. Pullan RD, Rhodes J, Ganesh S, Mani V, Morris JS, Williams GT, Newcombe RG, Russell MA, Feyerabend C, Thomas GA, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994;330:811-815.
183. Pullan RD. Colonic mucus, smoking and ulcerative colitis. Ann R Coll Surg Engl 1996;78:85-91.
184. Killen JD, Fortmann SP, Telch MJ, Newman B. Are heavy smokers different from light smokers? A comparison after 48 hours without cigarettes. JAMA 1988;260:1581-1585.
185. Hildebrand BE, Nomikos GG, Bondjers C, Nisell M, Svensson TH. Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms. Psychopharmacology (Berl) 1997;129:348-356.
186. Hildebrand BE, Panagis G, Svensson TH, Nomikos GG. Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area. Neuropsychopharmacology 1999;21: 560-574.
187. Herning RI, Jones RT, Bachman J. EEG changes during tobacco withdrawal. Psychophysiology 1983;20:507-512.
188. Henningfield J, Keenan R, Clarke P. Nicotine. In: Schuster CR, Kuhar MJ, editors. Pharmacological aspects of drug dependence: toward an integrated neurobehavioral approach. Berlin: Springer-Verlag; 1996. pp. 271-314.
189. Henningfield JE. Nicotine medications for smoking cessation. N Engl J Med 1995;333:1196-1203.
190. Killen JD, Fortmann SP, Kraemer HC, Varady A, Newman B. Who will relapse? Symptoms of nicotine dependence predict long-term relapse after smoking cessation. J Consult Clin Psychol 1992;60:797-801.
191. Killen JD, Fortmann SP. Role of nicotine dependence in smoking relapse: results from a prospective study using population-based recruitment methodology. Int J Behav Med 1994;1:320-334.
192. Killen JD, Fortmann SP. Craving is associated with smoking relapse: findings from three prospective studies. Exp Clin Psychopharmacol 1997;5:137-142.
193. Killen JD, Fortmann SP, Newman B, Varady A. Prospective study of factors influencing the development of craving associated with smoking cessation. Psychopharmacology (Berl) 1991;105: 191-196.
194. Fortmann SP, Killen JD. Nicotine gum and self-help behavioral treatment for smoking relapse prevention: results from a trial using population-based recruitment. J Consult Clin Psychol 1995; 63:460-468.
195. Hughes JR, Gulliver SB, Fenwick JW, Valliere WA, Cruser K, Pepper S, Shea P, Solomon LJ, Flynn BS. Smoking cessation among self-quitters. Health Psychol 1992;11:331-334.
196. Garvey AJ, Bliss RE, Hitchcock JL, Heinold JW, Rosner B. Predictors of smoking relapse among self-quitters: a report from the Normative Aging Study. Addict Behav 1992;17:367-377.
197. Russell MA, Merriman R, Stapleton J, Taylor W. Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking. Br Med J (Clin Res Ed) 1983;287:1782-1785.
198. Sachs DP, Hodgkin JE, Bostrom AG. Improving treatment outcome in the face of increasingly severe nicotine dependence in patients seeking tobacco-dependence treatment. Chest 2008;134: s53002.
199. Hughes JR. The hardening hypothesis: is the ability to quit decreasing due to increasing nicotine dependence? A review and commentary. Drug Alcohol Depend 2011;117: 111-117.
200. Report of the Committee on Safety of Medicines Working Group on nicotine replacement therapy. Medicines and Healthcare Products Regulatory Agency (UK). 2005 [accessed 2014 May 16]. Available from: http://www.ihra.net/files/2011/07/13/MHRA-Report-on-Nicotine-Replacement-Therapy.pdf
201. Medicines and Healthcare products Regulatory Agency (MHRA). New advice on use of nicotine replacement therapy (NRT): wider access in at-risk populations [accessed 2015 Jul 16]. Available from: http://www.nhsgrampian.org/grampianfoi/files/IMPACT052.doc
202. Tønnesen P, Carrozzi L, Fagerström KO, Gratziou C, Jimenez-Ruiz C, Nardini S, Viegi G, Lazzaro C, Campell IA, Dagli E, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J 2007;29: 390-417.
203. Sachs D. Tobacco dependence: pathophysiology and treatment. In: Hodgkin JE, Celli BR, Connors GL, editors. Pulmonary rehabilitation: guidelines to success, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, Inc; 2000. pp. 261-301.
204. Sachs D. Medical management of tobacco dependence: concepts and treatment objectives. In: Hodgkin JE, Celli BR, Connors GL, editors. Pulmonary rehabilitation: guidelines to success, 4th ed. St. Louis, MO: Mosby Elsevier; 2009. pp. 234-68.
205. Hyland A, Rezaishiraz H, Giovino G, Bauer JE, Michael Cummings K. Over-the-counter availability of nicotine replacement therapy and smoking cessation. Nicotine Tob Res 2005;7:547-555.
206. Benowitz NL, Zevin S, Jacob P III. Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. J Pharmacol Exp Ther 1998;287:958-962.
207. Lemmens V, Oenema A, Knut IK, Brug J. Effectiveness of smoking cessation interventions among adults: a systematic review of reviews. Eur J Cancer Prev 2008;17:535-544.
208. Leone FT, Evers-Casey S. Behavioral interventions in tobacco dependence. Prim Care 2009;36:489-507.
209. Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, Carson JL. Triple-combination pharmacotherapy for medically ill smokers: a randomized trial. Ann Intern Med 2009; 150:447-454.
210. Hays JT, Wolter TD, Eberman KM, Croghan IT, Offord KP, Hurt RD. Residential (inpatient) treatment compared with outpatient treatment for nicotine dependence. Mayo Clin Proc 2001;76: 124-133.
211. Hays JT, Croghan IT, Schroeder DR, Burke MV, Ebbert JO, McFadden DD, Hurt RD. Residential treatment compared with outpatient treatment for tobacco use and dependence. Mayo Clin Proc 2011;86:203-209.
212. Ebbert JO, Burke MV, Hays JT, Hurt RD. Combination treatment with varenicline and nicotine replacement therapy. Nicotine Tob Res 2009;11:572-576.
213. Ebbert JO, Croghan IT, Sood A, Schroeder DR, Hays JT, Hurt RD. Varenicline and bupropion sustained-release combination therapy for smoking cessation. Nicotine Tob Res 2009;11: 234-239.
214. Abroms LC, Lee Westmaas J, Bontemps-Jones J, Ramani R, Mellerson J. A content analysis of popular smartphone apps for smoking cessation. Am J Prev Med 2013;45:732-736.
215. Buller DB, Borland R, Bettinghaus EP, Shane JH, Zimmerman DE. Randomized trial of a smartphone mobile application compared to text messaging to support smoking cessation. Telemed J E Health 2014;20:206-214.
216. Drummond MB, Upson D. Electronic cigarettes: potential harms and benefits. Ann Am Thorac Soc 2014;11:236-242.
217. Caponnetto P, Campagna D, Papale G, Russo C, Polosa R. The emerging phenomenon of electronic cigarettes. Expert Rev Respir Med 2012;6:63-74.
218. Vickerman KA, Carpenter KM, Altman T, Nash CM, Zbikowski SM. Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine Tob Res 2013;15:1787-1791.
219. Li J, Bullen C, Newcombe R, Walker N, Walton D. The use and acceptability of electronic cigarettes among New Zealand smokers. N Z Med J 2013;126:48-57.
220. Popova L, Ling PM. Perceptions of relative risk of snus and cigarettes among US smokers. Am J Public Health 2013;103: e21-e23.
221. Adkison SE, O'Connor RJ, Bansal-Travers M, Hyland A, Borland R, Yong H-H, Cummings KM, McNeill A, Thrasher JF, Hammond D, et al. Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med 2013;44:207-215.
222. King BA, Alam S, Promoff G, Arrazola R, Dube SR. Awareness and ever-use of electronic cigarettes among U.S. adults, 2010-2011. Nicotine Tob Res 2013;15:1623-1627.
223. Centers for Disease Control and Prevention (CDC). Notes from the field: electronic cigarette use among middle and high school students-United States, 2011-2012. MMWR Morb Mortal Wkly Rep 2013;62:729-730.
224. Popova L, Ling PM. Alternative tobacco product use and smoking cessation: a national study. Am J Public Health 2013;103: 923-930.
225. Benowitz NL. Emerging nicotine delivery products. Implications for public health. Ann Am Thorac Soc 2014;11:231-235.
226. Pedersen W, von Soest T. Tobacco use among Norwegian adolescents: from cigarettes to snus. Addiction 2014;109: 1154-1162.
227. Post A, Gilljam H, Rosendahl I, Bremberg S, Galanti MR. Symptoms of nicotine dependence in a cohort of Swedish youths: a comparison between smokers, smokeless tobacco users and dual tobacco users. Addiction 2010;105: 740-746.
228. Timberlake DS, Huh J, Lakon CM. Use of propensity score matching in evaluating smokeless tobacco as a gateway to smoking. Nicotine Tob Res 2009;11:455-462.
229. Rapgay L, Bystrisky A. Classical mindfulness: an introduction to its theory and practice for clinical application. Ann N Y Acad Sci 2009;1172:148-162.
230. Elwafi HM, Witkiewitz K, Mallik S, Thornhill TA IV, Brewer JA. Mindfulness training for smoking cessation: moderation of the relationship between craving and cigarette use. Drug Alcohol Depend 2013;130:222-229.
231. Jain S, Shapiro SL, Swanick S, Roesch SC, Mills PJ, Bell I, Schwartz GE. A randomized controlled trial of mindfulness meditation versus relaxation training: effects on distress, positive states of mind, rumination, and distraction. Ann Behav Med 2007;33:11-21.
232. Brewer JA, Mallik S, Babuscio TA, Nich C, Johnson HE, Deleone CM, Minnix-Cotton CA, Byrne SA, Kober H, Weinstein AJ, et al. Mindfulness training for smoking cessation: results from a randomized controlled trial. Drug Alcohol Depend 2011;119:72-80.
233. Sachs DP, Säwe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med 1993;153:1881-1890.
234. Paoletti P, Fornai E, Maggiorelli F, Puntoni R, Viegi G, Carrozzi L, Corlando A, Gustavsson G, Säwe U, Giuntini C. Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch. Eur Respir J 1996;9:643-651.
235. Schnoll RA, Patterson F, Wileyto EP, Tyndale RF, Benowitz N, Lerman C. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol Biochem Behav 2009;92:6-11.
236. Schnoll RA, Leone FT. Biomarkers to optimize the treatment of nicotine dependence. Biomarkers Med 2011;5: 745-761.
237. Muramoto ML, Leischow SJ, Sherrill D, Matthews E, Strayer LJ. Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation. Arch Pediatr Adolesc Med 2007;161:1068-1074.
238. Colby SM, Gwaltney CJ. Pharmacotherapy for adolescent smoking cessation. JAMA 2007;298:2182-2184.
239. Glantz SA, Barnes DE, Bero L, Hanauer P, Slade J. Looking through a keyhole at the tobacco industry: the Brown and Williamson documents. JAMA 1995;274:219-224.
240. American Thoracic Society. ATS policy governing relationships between the tobacco industry, ATS members, and non-members who participate in ATS activities [accessed 2014 May 23]. Available from: http://www.thoracic.org/about/governance/ethics-and-coi/resources/ats-tobacco-policy-may2013.pdf